We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $384M
1-Year Est. Return 10.32%
This Fund
S&P 500
This Quarter Est. Return
-0.63%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$1.52B
AUM Growth
+$6.76M
Cap. Flow
+$42.3M
Cap. Flow %
2.79%
Top 10 Hldgs %
27.44%
Holding
435
New
29
Increased
184
Reduced
112
Closed
75

Top Buys

1
BMY icon
Bristol-Myers Squibb
BMY
+$21.1M
2
FSLR icon
First Solar
FSLR
+$15.7M
3
UTHR icon
United Therapeutics
UTHR
+$14.9M
4
HUM icon
Humana
HUM
+$14.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$13.4M

Top Sells

1
KMB icon
Kimberly-Clark
KMB
+$17M
2
ED icon
Consolidated Edison
ED
+$12.7M
3
EOG icon
EOG Resources
EOG
+$10.4M
4
ES icon
Eversource Energy
ES
+$9.97M
5
DGX icon
Quest Diagnostics
DGX
+$9.72M

Sector Composition

1 Healthcare 33.75%
2 Consumer Staples 26.59%
3 Technology 8.26%
4 Communication Services 7.04%
5 Financials 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
26
Verizon
VZ
$183B
$24.3M 1.6%
625,555
+72,665
+13% +$2.87M
KMB icon
27
Kimberly-Clark
KMB
$36.2B
$24M 1.58%
178,854
-130,652
-42% -$17M
DGX icon
28
Quest Diagnostics
DGX
$23.2B
$22.8M 1.5%
161,071
-67,972
-30% -$9.72M
LLY icon
29
Eli Lilly
LLY
$1.04T
$22.4M 1.47%
65,086
-18,359
-22% -$6.19M
MRNA icon
30
Moderna
MRNA
$25.1B
$22.1M 1.46%
144,071
+11,345
+9% +$1.87M
FSLR icon
31
First Solar
FSLR
$22.8B
$21M 1.39%
96,658
+86,254
+829% +$15.7M
HSY icon
32
Hershey
HSY
$35.4B
$20.2M 1.33%
79,356
+44,536
+128% +$10.5M
KR icon
33
Kroger
KR
$35.9B
$18.6M 1.22%
376,369
+3,346
+0.9% +$153K
SEDG icon
34
SolarEdge
SEDG
$3.18B
$18.6M 1.22%
61,101
+1,743
+3% +$531K
EPAM icon
35
EPAM Systems
EPAM
$4.58B
$17.7M 1.17%
59,328
+18,141
+44% +$5.84M
BAX icon
36
Baxter International
BAX
$12.1B
$16.3M 1.08%
402,927
+23,474
+6% +$995K
DVA icon
37
DaVita
DVA
$15B
$16.2M 1.07%
199,593
-4,975
-2% -$399K
BIIB icon
38
Biogen
BIIB
$30.8B
$15.8M 1.04%
56,832
-21,678
-28% -$6M
MCK icon
39
McKesson
MCK
$98.5B
$15.5M 1.02%
43,671
+26,986
+162% +$9.75M
SNAP icon
40
Snap
SNAP
$7.89B
$14.8M 0.97%
1,316,167
-1,330
-0.1% -$14K
AEM icon
41
Agnico Eagle Mines
AEM
$68.6B
$13.3M 0.88%
262,217
-122,962
-32% -$6.31M
CF icon
42
CF Industries
CF
$18.2B
$12.3M 0.81%
169,295
-40
-0% -$3.27K
REGN icon
43
Regeneron Pharmaceuticals
REGN
$71.2B
$12.1M 0.8%
14,729
-5,577
-27% -$4.21M
RCI icon
44
Rogers Communications
RCI
$18.8B
$10.7M 0.71%
232,451
+2,653
+1% +$126K
OXY icon
45
Occidental Petroleum
OXY
$53.4B
$10.1M 0.67%
162,467
-49,848
-23% -$3.1M
LCID icon
46
Lucid Motors
LCID
$2.52B
$9.75M 0.64%
121,284
+56,207
+86% +$4.99M
CAG icon
47
Conagra Brands
CAG
$6.92B
$9.52M 0.63%
253,433
-83,970
-25% -$3.11M
GME icon
48
GameStop
GME
$9.84B
$9.42M 0.62%
409,257
+32,590
+9% +$649K
FANG icon
49
Diamondback Energy
FANG
$53.5B
$7.89M 0.52%
58,375
+30,503
+109% +$4.25M
T icon
50
AT&T
T
$153B
$6.85M 0.45%
355,974
+216,426
+155% +$4.14M
1
2
3 4 5

Similar funds

PCM
Pinnbrook Capital Management New York $384M AUM 147.48% 1-Year Est. Return
DFA
Delta Financial Advisors New Orleans, Louisiana $384M AUM 26.86% 1-Year Est. Return
BAMG
Brand Asset Management Group Chesterfield, Missouri $385M AUM 22.41% 1-Year Est. Return
DR
Davis Rea Toronto, Ontario, Canada $384M AUM 11.74% 1-Year Est. Return
GCP
Garda Capital Partners Wayzata, Minnesota $385M AUM 7.25% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
GA
GSG Advisors Mount Laurel, New Jersey $385M AUM 19.83% 1-Year Est. Return
VI
VectorGlobal IAG Miami, Florida $385M AUM

TOBAM's Q1 2023 Portfolio in Review

As of Q1 2023, TOBAM held 435 positions worth $1.52B, up 0.45% from $1.51B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

TOBAM's Q1 2023 filing shows 29 new, 184 increased, 112 reduced and 75 closed positions. Its largest new stake was Bausch Health: 308,486 shares worth $2.49M. The largest sale was Kimberly-Clark, an estimated $17M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Technology.

  • TOBAM's largest Q1 2023 buy was Bausch Health: 308,486 shares worth $2.49M.
  • TOBAM added most to Bristol-Myers Squibb in Q1 2023, an estimated $21.1M increase.
  • TOBAM's biggest Q1 2023 reduction was Kimberly-Clark, cutting an estimated $17M.
  • TOBAM fully exited Stantec in Q1 2023, selling an estimated $1.26M.
  • TOBAM's ten largest holdings make up 27% of its $1.52B portfolio in Q1 2023.
  • TOBAM opened 29 new positions and closed 75 in Q1 2023.
  • TOBAM's portfolio value rose 0.45% quarter-over-quarter to $1.52B.

Based on TOBAM's 13F filing for Q1 2023, filed 3 May 2023.